StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Biogen (BIIB) PT Lowered to $311 at RBC Capital
April 25, 2018 7:43 AM
RBC Capital lowered its price target ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS View
Analyst PT Change
Next Articles
Biogen (BIIB) PT Lowered to $272 at Cantor Fitzgerald
April 26, 2018 1:49 AM
Biogen (BIIB) PT Raised to $369 at Morgan Stanley
April 25, 2018 7:24 AM
Biogen (BIIB) PT Lowered to $375 at Oppenheimer
April 25, 2018 7:15 AM
Biogen (BIIB) PT Lowered to $325 at Leerink Partners
April 25, 2018 6:37 AM
Biogen (BIIB) PT Lowered to $385 at Guggenheim
April 25, 2018 2:03 AM
UPDATE: Baird Upgrades Biogen (BIIB) to Outperform
April 25, 2018 1:08 AM
UPDATE: Goldman Sachs Downgrades Biogen (BIIB) to Buy
April 25, 2018 12:56 AM
Form 10-Q BIOGEN INC. For: Mar 31
April 24, 2018 4:55 PM
Biogen (BIIB) PT Lowered to $353 at Piper Jaffray
April 24, 2018 1:30 PM
Pre-Open Movers 04/24: (EVLV) (SANM) (WFT) Higher; (EPZM) (WAT) (MMM) Lower (more...)
April 24, 2018 9:06 AM
Piper Jaffray Remains Bullish on Biogen (BIIB) Following 1Q
April 24, 2018 8:48 AM
Biogen (BIIB) Tops Q1 EPS by 13c, Miss on Revenues
April 24, 2018 7:00 AM
Biogen Reports Quarterly Revenues of $3.1 Billion
April 24, 2018 6:59 AM
